Skip to main content

Table 1 Clinical features of the patient with jaundice

From: Identification of a novel splicing mutation in the SLC25A13 gene from a patient with NICCD: a case report

Index

Test result

Range

Blood cell counting

 WBC

15.80 × 109/L

3.5–9.5 × 109/L

 RBC

3.63 × 1012/L

3.8–5.1 × 1012/L

 PLT

359.0 × 109/L

125.0–350.0 × 109/L

 Hb

94.0 g/L

115.0–150.0 g/L

Blood biochemistry

 GLU

3.80 mmol/L

4.1–6.5 mmol/L

 LAC

5.25 mmol/L

0.5–2.2 mmol/L

 ALT

65 U/L

4–33 U/L

 AST

160 U/L

4–32 U/L

 TBIL

156.6 μmol/L

3.4–20.5 μmol/L

 DBIL

121.6 μmol/L

0–10 μmol/L

 IBIL

35.0 μmol/L

1.5–16.5 μmol/L

 TG

3.08 mmol/L

0.05–1.7 mmol/L

 TBA

210.6 μmol/L

1.0–10 μmol/L

 BUA

198.6 μmol/L

142.8–339.2 μmol/L

 BA

57 μmol/L

18–72 μmol/L

 PCT

2.92 ng/mL

0.02–0.05 ng/mL

 AFP

47,328 ng/mL

<  25 ng/mL

Immunology

 IgA

0.13 g/L

0.82–4.53 g/L

 IgG

5.50 g/L

6.6–17.5 g/L

 IgM

0.66 g/L

0.46–3.04 g/L

 C3

0.54 g/L

0.16–0.38 g/L

 C4

0.11 g/L

0.22–0.58 g/L

  1. WBC White blood cell, RBC Red blood cell, PLT Platelet, Hb hemoglobin, GLU Blood glucose, LAC Lactic acid, ALT glutamic-pyruvic transaminase, AST Glutamic oxalacetic transaminase, TBIL Total bilirubin, DBIL Direct bilirubin, IBIL Indirect bilirubin, TG Triglyceride, TBA Total bile acid, BUA Blood uric acid, BA blood ammonia, PCT Procalcitonin, AFP alpha fetoprotein